NHS consults public on plans to restrict access to over-the-counter drugsBMJ 2017; 359 doi: https://doi.org/10.1136/bmj.j5921 (Published 22 December 2017) Cite this as: BMJ 2017;359:j5921
- Gareth Iacobucci
- The BMJ
The NHS has launched a public consultation on plans to restrict access to a range of drugs that can be bought over the counter for minor, short term conditions, which it says will free up £136m (€154m; $182m) a year to spend on more effective treatments.
It comes after NHS England agreed at its board meeting on 30 November1 to consult on the plans as part of a drive to reduce costs and unwarranted variation.
The consultation,2 which runs until 14 March 2018, proposes developing national guidance for clinical commissioning groups (CCGs) on limiting GPs’ prescribing of over-the-counter products for 35 minor or self limiting conditions.
NHS England said the plans, …